article thumbnail

Janssen leads effort to cut waste in digital health devices

pharmaphorum

.” The programme has been set up to develop four devices – an e-paper label, smart wearable sensor, smart pill box, and endo-cutter used in surgical procedures – with funding from the EU’s Horizon Europe programme and support from the Waste Electrical and Electronic Equipment (WEEE) Forum.

Leads 119
article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

With the advent of electronic health records, social media, and other digital sources, pharmaceutical companies now have access to vast amounts of data that can be used to inform their marketing strategies. Additionally, companies must ensure that the data they collect is accurate and reliable, and that it is used ethically and responsibly.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

With the advent of electronic health records, social media, and other digital sources, pharmaceutical companies now have access to vast amounts of data that can be used to inform their marketing strategies. Additionally, companies must ensure that the data they collect is accurate and reliable, and that it is used ethically and responsibly.

article thumbnail

Evolution of ePROM: Advancements, Concerns, and the Way Forward

PM360

Electronic Patient-Reported Outcome Measures (ePROMs) are now allowing these patients to self-report health conditions and treatment effectiveness remotely. Furthermore, in 46.15% of cases, ePROMs guided primary care teams in making ethical decisions. Monitoring Changes in the Clinical Status Remotely.

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

This can be achieved by implementing electronic systems with built-in controls to maintain data integrity, audit trails and access controls. Fostering an integrity culture and ethical behaviour is crucial for ensuring that employees feel empowered to raise concerns, report incidents, and adhere to established policies and procedures.

article thumbnail

Mastering the Art of Presentation: Choosing the Perfect Sample Bag for Pharma Sales Success

Contrarian Sales Techniques

The ideal sample bag should be spacious enough to hold all necessary samples, literature, and electronic devices like tablets or laptops. Professional Appearance: Reflecting Brand Values Finally, the appearance of the sample bag should align with the professional and ethical standards of the pharmaceutical industry.

Sales 52
article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

The rule applies to developers of Certified Electronic Health Record Technology (CEHRT), particularly those who incorporate predictive decision support interventions (DSIs) into their products. The HTI-1 Final Rule is an AI disclosure and governance rule published by the US Department of Health and Human Services (HHS).